Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TPST · NASDAQ · Pharmaceutical Preparations
$0.287−0.0189 (−6.18%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Tempest Therapeutics (TPST) · oqro.io/stocks/TPST · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Mar 24, 2026 · Filed Mar 25, 2026
CEO purchased ~$500K of TPST shares in the open marketSource